Cargando…
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
To ensure optimal prescribing practices in the dolutegravir-era in Cameroon, we compared first-line virological response (VR) under tenofovir + lamivudine + dolutegravir (TLD) according to prior exposure to tenofovir + lamivudine + efavirenz (TLE). A facility-based survey was conducted among patient...
Autores principales: | Semengue, Ezechiel Ngoufack Jagni, Fokam, Joseph, Etame, Naomi-Karell, Molimbou, Evariste, Chenwi, Collins Ambe, Takou, Désiré, Mossiang, Leonella, Meledie, Alain P., Yagai, Bouba, Nka, Alex Durand, Dambaya, Beatrice, Teto, Georges, Ka’e, Aude Christelle, Beloumou, Grâce Angong, Djupsa Ndjeyep, Sandrine Claire, Abba, Aissatou, Kengni, Aurelie Minelle Ngueko, Tommo Tchouaket, Michel Carlos, Bouba, Nounouce Pamen, Billong, Serge-Clotaire, Sosso, Samuel Martin, Colizzi, Vittorio, Perno, Carlo-Federico, Kouanfack, Charles, Zoung-Kanyi Bissek, Anne-Cecile, Eben-Moussi, Emmanuel, Santoro, Maria Mercedes, Ceccherini-Silberstein, Francesca, Ndjolo, Alexis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866637/ https://www.ncbi.nlm.nih.gov/pubmed/36680058 http://dx.doi.org/10.3390/v15010018 |
Ejemplares similares
-
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
por: Fokam, Joseph, et al.
Publicado: (2022) -
HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023) -
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023) -
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023) -
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
por: Fokam, Joseph, et al.
Publicado: (2020)